Physician

Mark Jay Saslawsky, M.D.

According to 2025 Medicare claims, Mark Saslawsky, M.D. (NPI: 1184739401) practices urology in the Memphis, TN-MS-AR market, with the plurality of this provider's patient population coming from Tate, MS. This provider's primary affiliated billing organization is SOUTHEAST UROLOGY NETWORK PC (NPI: 1184770356; TIN: 621443451) and primary practice location at 38119-0882.

Saslawsky's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 787 traditional Medicare patients, billed 9,466 HCPCS/CPT codes, and received $676,846 in Medicare payments. The top billing code was 36415 (Insertion of needle into vein for collection of blood sample). Part D data shows 2,648 prescription claims across 565 beneficiaries totaling $7,122,534 in drug costs, led by Xtandi (Enzalutamide). DME data shows 59 claims. Open Payments data shows 101 records totaling $5,162. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $245,555 to $676,846. Similarly, Part D prescription costs have risen steadily, from $270,407 to $7,122,534. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	718	12,774	$245,555
2016	772	12,549	$227,018
2017	741	10,692	$226,845
2018	805	10,829	$504,149
2019	913	18,712	$590,032
2020	973	29,860	$533,919
2021	973	16,303	$600,940
2022	811	15,515	$323,156
2023	800	9,924	$310,206
2024	787	9,466	$676,846

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	358	1,557	$270,407
2016	371	1,672	$369,196
2017	404	1,642	$290,756
2018	408	1,759	$616,850
2019	419	1,741	$1,095,550
2020	491	2,033	$2,337,880
2021	495	2,165	$2,986,000
2022	475	1,981	$3,016,255
2023	479	2,049	$3,323,316
2024	565	2,648	$7,122,534

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	88	$9,282
2016	N/R	82	$8,533
2017	N/R	102	$8,496
2018	N/R	99	$8,451
2019	N/R	96	$11,202
2020	N/R	81	$11,082
2021	N/R	76	$10,170
2022	N/R	58	$16,820
2023	N/R	48	$13,373
2024	N/R	59	$20,545

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
36415	Insertion of needle into vein for collection of blood sample	537	925	$9
51798	Ultrasound measurement of bladder capacity after voiding	504	757	$7
82044	Urine microalbumin (protein) analysis	639	1,142	$6
82570	Creatinine level to test for kidney function or muscle injury	639	1,142	$5
81003	Automated urinalysis test	639	1,142	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	340	10,200	$4,629,842
Erleada	Apalutamide	120	3,600	$1,745,558
Xgeva	Denosumab	68	1,920	$212,801
Orgovyx	Relugolix	80	2,400	$204,710
Nubeqa	Darolutamide	12	360	$144,062

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	28	$15,971
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	31	$4,575

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	101	$5,162	COLOPLAST CORP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mark Jay Saslawsky, M.D.?

Tedicare shows public-source Medicare data for Mark Jay Saslawsky, M.D. (NPI 1184739401), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark Jay Saslawsky, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mark Jay Saslawsky, M.D.?

Mark Jay Saslawsky, M.D. is linked to SOUTHEAST UROLOGY NETWORK PC (billing NPI 1184770356) in the available physician profile data.

Does Mark Jay Saslawsky, M.D. have Open Payments data?

Mark Jay Saslawsky, M.D. has 101 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.